Skip to main content

Surveillance of the Upper Tract After Conservative Treatment

  • Chapter
  • First Online:
  • 393 Accesses

Abstract

Surveillance is essential following endoscopic treatment for upper tract urothelial carcinoma. However unlike lower tract disease, surveillance cannot be performed in an outpatient basis. It is therefore critical to have a multidisciplinary approach to ensure follow-up. Conservative treatment which involves multiple invasive procedures can be cumbersome, for the patient and constant physician–patient dialogue must be maintained. We will outline the optimal approach in explaining to a patient and their families, what surveillance entails. Our surveillance protocol involves flexible cystoscopy, CT or MR urogram, and upper endoscopy in first 3 months. This is followed by repeat ureteroscopy, cytologies, cystoscopies, and imaging in 3–6 month intervals.

This is a preview of subscription content, log in via an institution.

References

  1. Motamedinia P, Keheila M, Leavitt DA, Rastinehad AR, Okeke Z, Smith AD. The expanded use of percutaneous resection for upper tract urothelial carcinoma: a 30-year comprehensive experience. J Endourol. 2016 Mar;30(3):262–7.

    Article  PubMed  Google Scholar 

  2. Cutress ML, Stewart GD, Zakikhani P, Phipps S, Thomas BG, Tolley DA. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review. BJU Int. 2012;110(5):614–28.

    Article  PubMed  Google Scholar 

  3. Thompson RH, Krambeck AE, Lohse CM, Elliott DS, Patterson DE, Blute ML. Endoscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. Urology. 2008;71(4):713–7.

    Article  PubMed  Google Scholar 

  4. Krambeck AE, Thompson RH, Lohse CM, Patterson DE, Elliott DS, Blute ML (2007) Imperative indications for conservative management of upper tract transitional cell carcinoma. J Urol 178(3 Pt 1):792–6; (discussion 6–7).

    Article  PubMed  Google Scholar 

  5. Thompson RH, Krambeck AE, Lohse CM, Elliott DS, Patterson DE, Blute ML. Elective endoscopic management of transitional cell carcinoma first diagnosed in the upper urinary tract. BJU Int. 2008;102(9):1107–10.

    Article  PubMed  Google Scholar 

  6. Rouprêt M, Babjuk M, Compérat E, Zigeuner R, Sylvester RJ, Burger M, et al. European association of urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update. Eur Urol. 2015;68(5):868–79.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Author acknowledges the contribution of Gerald Matthews, MD, Westchester Medical Health Network, New York Medical College, Valhalla, NY and thanks him for his helpful comments and feedback.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joel Hillelsohn .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hillelsohn, J., Eshghi, M. (2018). Surveillance of the Upper Tract After Conservative Treatment. In: Eshghi, M. (eds) Urothelial Malignancies of the Upper Urinary Tract. Springer, Cham. https://doi.org/10.1007/978-3-319-51263-1_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-51263-1_26

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-51261-7

  • Online ISBN: 978-3-319-51263-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics